0001562180-23-007922.txt : 20231127 0001562180-23-007922.hdr.sgml : 20231127 20231127163819 ACCESSION NUMBER: 0001562180-23-007922 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231123 FILED AS OF DATE: 20231127 DATE AS OF CHANGE: 20231127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brown Brian Lee CENTRAL INDEX KEY: 0001847811 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38148 FILM NUMBER: 231440724 MAIL ADDRESS: STREET 1: 5322 W. BRIAR PARK ROAD CITY: HERRIMAN STATE: UT ZIP: 84096 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Co-Diagnostics, Inc. CENTRAL INDEX KEY: 0001692415 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 462609396 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4049 SOUTH HIGHLAND DRIVE CITY: SALT LAKE CITY STATE: UT ZIP: 84124 BUSINESS PHONE: 8012789769 MAIL ADDRESS: STREET 1: 4049 SOUTH HIGHLAND DRIVE CITY: SALT LAKE CITY STATE: UT ZIP: 84124 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2023-11-23 false 0001692415 Co-Diagnostics, Inc. CODX 0001847811 Brown Brian Lee C/O CO-DIAGNOSTICS, INC. 2401 S. FOOTHILL DRIVE, SUITE D SALT LAKE CITY UT 84109 false true false false Chief Financial Officer false Common Stock 2023-11-23 4 A false 118332.00 0.00 A 249345.00 D Common Stock 2023-11-23 4 D false 36125.00 1.26 D 213220.00 D Restricted Stock Unit 0.00 2023-11-23 4 M false 118332.00 0.00 D Common Stock 521666.00 403334.00 D Included in 30,000 restricted stock units awarded to the Reporting Person on February 22, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on May 24, 2021. Included in 100,000 restricted stock units awarded to the Reporting Person on August 12, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2021. Included in 225,000 restricted stock units awarded to the Reporting Person on June 6, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2022. Included in 130,000 restricted stock units awarded to the Reporting Person on January 17, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on May 23, 2023. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSU's. This sale is mandated by the Issuer's election, under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. /s/ Brian L. Brown 2023-11-27